Daniel K Spiegelman's Net Worth

Daniel K Spiegelman's net worth is estimated to be at least $15,939,603.82 as of 11/23/2024. CoreStreet's estimation of Daniel K Spiegelman's net worth is based on their sale of stock and current holding of stock.

Daniel K Spiegelman is Director at Myriad Genetics Inc. They have executed at least 25 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,788 units of MYGN stock on 06/03/2024. Their biggest sale was on 03/01/2017 when they sold 35,000 units of Biomarin Pharmaceutical Inc stock for $3,292,450.00. They typically trade 2 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $15,939,603.82
Most recent insider trade:
  • June 3, 2024

Daniel K Spiegelman's Insider Trading History

Myriad Genetics IncTitleAmountPriceTypeTotal Value
June 3, 2024
Director3,788$22.04Sell$83,487.52
June 2, 2023
Director8,638$23.01Sell$198,760.38
Biomarin Pharmaceutical IncTitleAmountPriceTypeTotal Value
April 1, 2019
CFO13,473$89.00Sell$1,199,097.00
March 27, 2019
CFO100$90.00Sell$9,000.00
June 22, 2018
CFO10,000$99.00Sell$990,000.00
April 23, 2018
CFO11,059$82.15Sell$908,496.85
March 16, 2017
CFO1,989$91.96Sell$182,908.44
March 6, 2017
CFO2,303$93.32Sell$214,915.96
March 1, 2017
CFO35,000$94.07Sell$3,292,450.00
Jan. 9, 2017
CFO5,000$90.00Sell$450,000.00
Aug. 1, 2016
CFO4,000$99.33Sell$397,320.00
June 6, 2016
CFO1,649$89.14Sell$146,991.86
May 31, 2016
CFO20,841$89.88Sell$1,873,189.08
May 23, 2016
CFO3,769$87.07Sell$328,166.83
March 2, 2016
CFO4,623$86.12Sell$398,132.76
June 5, 2015
CFO1,649$122.30Sell$201,672.70
June 1, 2015
CFO5,523$124.73Sell$688,883.79
May 29, 2015
CFO1,578$126.15Sell$199,064.70
May 18, 2015
CFO2,059$124.77Sell$256,901.43
March 2, 2015
CFO15,500$107.00Sell$1,658,500.00
Sept. 2, 2014
CFO16,000$69.83Sell$1,117,280.00
Aug. 1, 2014
CFO2,229$61.76Sell$137,663.04
July 2, 2014
CFO2,229$64.00Sell$142,656.00
Sept. 4, 2013
CFO9,000$69.00Sell$621,000.00
July 1, 2013
CFO4,066$59.78Sell$243,065.48